Innovation, collaboration, and creativity

A new approach for research and development.

Transforming early scientific innovations into business partnership opportunities.

Ponte Vecchio, Florence, Italy
April 10, 2018

NEOMED Therapeutics 1 names Dr. Frank Giles as Chief Medical Officer

Read complete news
February 28, 2018

NEOMED Institute Launches NEOMED Therapeutics 1 Inc. to fund and develop a dual BET inhibitor anticancer therapy pipeline with NEO2734, an oral dual BET and CBP/P300 inhibitor, as lead compound

Read complete news
January 30, 2018

ARTELO BIOSCIENCES AND THE NEOMED INSTITUTE ENTER INTO AN EXCLUSIVE GLOBAL OPTION AND LICENSE AGREEMENT

Read complete news
image articles

See all the news

Portfolio

Our portfolio is managed according to industry standards, reducing the execution risk and maximizing value creation and the chances of commercial success.

Technoparc Montreal Site

Saint-Laurent

A high-tech research and development facility dedicated to the development of small molecule therapeutics, located in Technoparc Montréal’s Saint-Laurent Campus, acting as an open-access drug discovery hub, housing commercial companies and offering a unique environment to nurture collaboration, innovation, and creativity.

Learn more

Laval Biotech Site

Laval

A high-tech research and development facility dedicated to the development of biologics and vaccines, located in Laval, acting as an open-access drug discovery hub, housing commercial companies and offering a unique environment to nurture collaboration, innovation, and creativity.

Learn more
© 2018 NEOMED Institute. All Rights Reserved. // Solutions Web Globalia